| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $2.04B | +11.0% |
| Cost of Revenue | $1.28B | +7.2% |
| Gross Profit | $763.6M | +18.0% |
| R&D Expense | $16.7M | +7.7% |
| SG&A Expense | $514.0M | +6.7% |
| Operating Income | $249.6M | +50.8% |
| Pre-tax Income | $268.7M | +56.0% |
| Income Tax | $64.5M | +42.2% |
| Net Income | $204.2M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $500.6M | +21.9% |
| Short-term Investments | $191.7M | +71.3% |
| Accounts Receivable | $472.8M | +1.9% |
| Inventory | $36.7M | +0.1% |
| Current Assets | $1.25B | +16.9% |
| Total Assets | $1.92B | +9.1% |
| Current Liabilities | $244.3M | -21.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $278.8M | +37.2% |
| Capital Expenditures | $2.3M | -47.6% |
| Investing Cash Flow | -$139.9M | -18.3% |
| Financing Cash Flow | -$49.1M | +22.6% |
| Free Cash Flow | $276.5M | +39.1% |
| +60.9% |
| EPS (Basic) | $4.79 | +59.7% |
| EPS (Diluted) | $4.69 | +57.9% |
| Long-term Debt |
| $414.7M |
| +0.4% |
| Total Liabilities | $744.4M | -8.5% |
| Stockholders' Equity | $1.18B | +24.1% |